Michael T. Eadon
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Nephrology 22
- Chronic Kidney Disease and Diabetes 15
- Renal Diseases and Glomerulopathies 7
- Pharmacology 19
- Pharmacogenetics and Drug Metabolism 19
- Co-authors
- Patrick N. CunninghamBradley K. HackChang XuAnthony ChangSeth L. AlperTarek M. El‐AchkarPierre C. DagherSeth Winfree
- Journals
- Journal of the American Society of Nephrology (7 papers)Clinical Pharmacology & Therapeutics (4 papers)American Journal of Nephrology (4 papers)Clinical and Translational Science (3 papers)Kidney International (3 papers)
- Partner nations
- United StatesArgentinaFinland
In The Last Decade
Michael T. Eadon
80 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 115
- Nephrology 326
- Pharmacology 188
- Molecular Medicine 58
- Virology 51
- Transplantation 27
Countries citing papers authored by Michael T. Eadon
This map shows the geographic impact of Michael T. Eadon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Eadon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Eadon more than expected).
Fields of papers citing papers by Michael T. Eadon
This network shows the impact of papers produced by Michael T. Eadon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Eadon. The network helps show where Michael T. Eadon may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael T. Eadon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 34 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 37 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 27 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 28 | |
| 13 | 2021 | 13 | |
| 14 | 2020 | 4 | |
| 15 | Implementation of a Renal Precision Medicine Program: Clinician Attitudes and Acceptance | 2020 | 1 |
| 16 | 2019 | 41 | |
| 17 | 2018 | 22 | |
| 18 | Rifampin modulation of xeno- and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes | 2018 | 3 |
| 19 | 2018 | 9 | |
| 20 | In Vivo siRNA Delivery and Rebound of Renal LRP2 in Mice | 2017 | 1 |
About Michael T. Eadon
Michael T. Eadon is a scholar working on Nephrology, Pharmacology, Transplantation, Biophysics and Physiology, having authored 90 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (19 papers), Single-cell and spatial transcriptomics (15 papers), Chronic Kidney Disease and Diabetes (15 papers), Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (7 papers), Renal Diseases and Glomerulopathies (7 papers), Cell Image Analysis Techniques (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). The work is most often cited by research in Nephrology (326 citations), Pharmacology (188 citations), Molecular Medicine (58 citations), Virology (51 citations) and Transplantation (27 citations). Michael T. Eadon has collaborated with scholars based in United States, Argentina and Finland. Frequent co-authors include Patrick N. Cunningham, Bradley K. Hack, Chang Xu, Anthony Chang, Seth L. Alper, Tarek M. El‐Achkar, Pierre C. Dagher, Seth Winfree, Ricardo Melo Ferreira and Takashi Hato. Their work appears in journals such as Journal of the American Society of Nephrology, Clinical Pharmacology & Therapeutics, American Journal of Nephrology, Clinical and Translational Science and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.